Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

The third International Scientific Tendinopathy Symposium - New Approaches to Tendon Therapeutics - is being held in St Hilda's College, Oxford, on Friday 5 and Saturday 6 September. The event brings together an unprecedented mix of excellent basic and translational science and the finest clinical expertise.

In addition to the scientific meeting, featuring twelve international plenary speakers, along with open papers and poster sessions, there will be two satellite events on Sunday 7 September - a hands-on clinical workshop on tendinopathy and a consensus meeting on outcome measures.

The meeting has proved highly popular and is now fully booked, but you can follow the meeting and join the discussion on Twitter using hashtag #Tendons2014.

The Symposium is co-chaired by NDORMS Head of Department Professor Andrew Carr, Associate Professor Philippa Hulley, also of NDORMS and Associate Professor Mark Thompson, of the Institute of Biomedical Engineering, Oxford.

Speaking of the event, Prof Thompson says: "ISTS 2014 will pull together exciting plenary speakers, excellent scientists and expert clinicians in the inspiring surroundings of St Hilda's College to find new ways of treating painful and debilitating tendon disease. The meeting venue is full, but social media will take the conversations wider and further, and we will be posting video of the final discussion session."

The meeting proceedings will be published in the BJSM soon after the event.

For the first time in its three-edition history, the meeting is co-sponsored by the International Symposium on Ligaments and Tendons, while the commercial sponsors are the British Journal of Sports Medicine (BJSM), UTC Imaging BV, TRB Chemedica, Biomet, Mathys, RegenLab and Bose.

Prof Thompson has already spoken to BJSM about this year's Symposium and a podcast is online. This year's programme is also published.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.